Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 14 tags : Cancer save search
Accuray CyberKnife® Robotic Radiotherapy Platform is Superior to Conventional Linear Accelerators in Reducing Incidence of Bladder Side Effects in Prostate Cancer Patients
Published: 2021-09-14 (Crawled : 18:00) - biospace.com/
ARAY | $2.21 0.91% 0.9% 690K
|
Health Technology
|
| O: 1.09%
H: 0.15%
C: -4.58%
prostate cancer therapy cancer iot bladder
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium
Published: 2021-09-14 (Crawled : 12:15) - prnewswire.com
ANIX | News | $3.09 1.31% 1.29% 59K
|
Health Technology
|
| O: 3.82%
H: 0.19%
C: -7.16%
therapy car-t cancer ovarian cancer symposium
Galera to Host Virtual Key Opinion Leader Event on Radiotherapy-Induced Severe Oral Mucositis (SOM) in Patients with Head and Neck Cancer
Published: 2021-09-14 (Crawled : 12:00) - biospace.com/
GRTX | $0.185 -6.75% -7.24% 3.8M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: -3.26%
therapy cancer iot oral mucositis
Health Canada approves LUMAKRAS™ (sotorasib), the first and only targeted treatment for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
Published: 2021-09-14 (Crawled : 12:00) - biospace.com/
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.0%
H: 1.86%
C: 1.28%
treatment lung cancer cancer
Convergent Therapeutics and Point Biopharma Announce a Collaboration to Evaluate CONV 01-α (Rosopatamab-225Ac) in combination with PNT2002 for Progressive Metastatic Castration-Resistant Prostate Cancer
Published: 2021-09-14 (Crawled : 12:00) - biospace.com/
PNT | $13.68 2.63% 0.15% 0
|
|
| O: 0.33%
H: 12.2%
C: 1.96%
biopharma prostate cancer collaboration cancer
Novocure Announces Clinical Trial Collaboration with Roche to Evaluate Tumor Treating Fields as Part of a Novel Combination for the First-line Treatment of Metastatic Pancreatic Cancer
Published: 2021-09-14 (Crawled : 11:00) - novocure.com
NVCR | $12.04 -0.08% -0.08% 1.4M
|
Health Technology
|
| O: 1.68%
H: 0.14%
C: -4.27%
treatment collaboration cancer trial pancreatic pancreas
ROME Therapeutics Secures $77 Million in Series B Financing to Advance Repeatome-derived Pipeline for Cancer and Autoimmune Diseases and Expand Repeatomics Platform
Published: 2021-09-14 (Crawled : 11:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.85%
H: 0.06%
C: -0.68%
disease cancer
Exact Sciences and National Surgical Adjuvant Breast and Bowel Project Announce Clinical Validation Study to Detect Minimal Residual Disease in Colorectal Cancer Patients
Published: 2021-09-14 (Crawled : 10:00) - prnewswire.com
EXAS | $63.45 0.36% 0.36% 1.6M
|
Health Technology
|
| O: 0.57%
H: 0.22%
C: -3.18%
disease cancer colorectal cancer
Positive Interim Results of CHOICE-01 Study Evaluating Coherus' and Junshi Biosciences’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer
Published: 2021-09-14 (Crawled : 02:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.47%
H: 0.07%
C: -1.4%
CHRS | $1.99 -7.44% -8.04% 1.9M
|
Health Technology
|
| O: 0.31%
H: 0.49%
C: -0.86%
treatment lung cancer positive results cancer conference
Positive Interim Results of CHOICE-01 Study Evaluating Junshi Biosciences and Coherus’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer
Published: 2021-09-14 (Crawled : 02:00) - globenewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.47%
H: 0.07%
C: -1.4%
CHRS | $1.99 -7.44% -8.04% 1.9M
|
Health Technology
|
| O: 0.31%
H: 0.49%
C: -0.86%
treatment lung cancer positive results cancer conference
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.